Scalp Hypothermia for the Prevention of Chemotherapy-Induced Alopecia in Breast Cancer

    February 2024 in “ Journal of Modern Oncology
    Nikolai A. Ognerubov, Sergei V. Barsukov
    The study evaluated the efficacy of scalp hypothermia (SHT) in preventing chemotherapy-induced alopecia in 75 breast cancer patients. Conducted from 2016 to 2023, the study found that SHT, using the Orbis II device, resulted in complete hair preservation in 57.3% of patients. Grade 1 and 2 alopecia were observed in 25.4% and 12% of patients, respectively. Side effects were minimal, with 16% experiencing cold sensations or headaches, and 3 patients discontinuing due to intolerance. No scalp metastases were reported. Overall, SHT was deemed effective in reducing alopecia, aiding in patients' psychological and social well-being.
    Discuss this study in the Community →

    Research cited in this study

    20 / 20 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    1 / 1 results